Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

Botto, Marina, Hawkins, Philip N., Bickerstaff, Maria C.M., Herbert, Jeff, Bygrave, Anne E., Mcbride, Alan, Hutchinson, Winston L., Tennent, Glenys A. +2 more·1997·Nature Medicine
DOI 10.1038/nm0897-855

Cited by (239)

Items 201–239 of 239

  1. Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease
    Kate L. Sheehan, HyeSook Jeon, S. Corr, Jerrard M. Hayes, K.-H. Mok · 2024 · The Protein Journal
  2. Serum amyloid P component accumulates and persists in neurones following traumatic brain injury
    Ping K. Yip, Zhou-Hao Liu, Shumaila Hasan, M. Pepys, Christopher E. G. Uff · 2023 · Open Biology
  3. Extracellular Chaperones in Neuronal Proteinopathies: Protecting and Facilitating Neuronal Function
    S. Satapathy · 2017
  4. Insolubilome profiling defines molecular features that influence protein insolubility with aging
    Anna Stephan, Flávia A. Graça, Vishwajeeth Pagala, Liam C. Hunt, Chia-Lung Chuang, John Grime, Daniel Alford, Xusheng Wang, Anthony A. High, Junmin Peng et al. · 2026 · Developmental Cell
  5. Identifying Sex-Specific Serum Patterns of Alzheimer’s Mice through Deep TMT Profiling and a Concentration-Dependent Concatenation Strategy
    Kaushik Kumar Dey, Jay M. Yarbro, Danting Liu, Xian Han, Zhen Wang, Yun Jiao, Zhiping Wu, Shu Yang, Dong Geun Lee, Abhijit Dasgupta et al. · 2023 · Journal of Proteome Research
  6. Proteomic analysis of plasma after 4 weeks of intermittent fasting in mice
    A. Mascaro, G. D'Antona · 2013
  7. Inhibitors of Amyloid and Oligomer Formation
    Nikolai Lorenzen, Erich E. Wanker, Daniel E. Otzen · 2013 · Wiley eBooks
  8. Amyloidosis In Vivo: From Molecular Interactions to Therapeutic Targets
    R. Kisilevsky · 2004
  9. Combating ageing beyond the cell: Emerging roles of extracellular proteostasis
    Siddharth R. Venkatesh, I. Gallotta, B. Olabiyi, Yoon Hee Choi, Sarah Inglesfield, Janet R. Kumita, Collin Y. Ewald, D. David · 2026 · The FEBS Journal
  10. Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders
    Amand Floriaan Schmidt, Chris Finan, Sandesh Chopade, Stéphan Ellmerich, Martin N. Rossor, Aroon Dinesh Hingorani, Mark B. Pepys · 2023 · medRxiv
  11. A transgenic mouse model reproduces human hereditary systemic amyloidosis.
    M. Chabert, X. Rousset, M. Colombat, M. Lacasa, H. Kakanakou, Mathilde Bourderioux, P. Brousset, O. Burlet-Schiltz, J. Liepnieks, B. Kluve-beckerman et al. · 2019 · Kidney International
  12. Proteomics Approach Identifies Factors Associated With the Response to Low‐Density Lipoprotein Apheresis Therapy in Patients With Steroid‐Resistant Nephrotic Syndrome
    Emiko Kuribayashi‐Okuma, Shigeru Shibata, Shigeyuki Arai, Tatsuru Ota, Sumiyo T. Watanabe, Harumi Hisaki, Tomoki Okazaki, Tosifusa Toda, Shunya Uchida · 2016 · Therapeutic Apheresis and Dialysis
  13. Classical and alternative pathway complement activation are not required for reactive systemic AA amyloid deposition in mice
    W. Hutchinson, J. Herbert, M. Botto, M. Pepys · 2004 · Immunology
  14. Revisiting Glomerulopathy in Clusterin Knockout Mice: A Mouse Model of Human Immunotactoid Glomerulopathy
    Xing-Lan Li, Xingwei Cai, Q. Guan, Jun-Ya Tan, Xudan Yang, Chang-Mei Wu, Cai-Gan Du · 2025 · Nephrology
  15. Identifying the quantity profiles of amyloid signature proteins in different types of renal amyloidosis
    Shuang Wang, Dan-Yang Li, Xin Zhang, Fu-De Zhou, Su-Xia Wang · 2025 · BMC Nephrology
  16. Amyloidosis: Systems-Based Therapies
    Eileen Ly, A. Stephen, Yasmeen Alhomsy, Asal Homayouni, J. Fisher, K. Sheehan, P. Venkataraman, Quinto J. Gesiotto, M. Habib, M. Zabel · 2019 · Amyloid Diseases
  17. Developments in the Treatment of Amyloid A Amyloidosis Secondary to Rheumatoid Arthritis
    Tadashi Nakamura · 2016
  18. Accumulation of Serum Amyloid A fibrils in mouse brain following chronic Systemic Amyloidosis
    A. Chinnasamy · 2015 · Zenodo (CERN European Organization for Nuclear Research)
  19. [New trends in the treatment of amyloidosis].
    F. Martínez-Valle, Mercedes Gironella-Mesa, R. Solans-Laqué · 2012 · Medicina clínica (Ed. impresa)
  20. Pentraxins in the reactions of innate and aquired immunity, matrix organization, and female fertility
    P. Nazarov · 2010 · Medical academic journal
  21. Introduction, Aims, and Outline
    T. Nath, M. Jashimuddin, M. Inoue · 2016
  22. Mouse Models of Transthyretin Amyloidosis
    Sadahiro Ito, Shuichiro Maeda · 2009 · Springer eBooks
  23. Chapter 1 Amyloid and Amyloid-Like Protein Aggregates in Neurodegenerative Disease
    Todd Eliot Golde · 2007 · Blue books of neurology
  24. Exploring hemopexin's antibacterial activity in bony fish: An immunological study of PoHpx-a
    Sheng-Han Gao, Yi-qi zhou, Wen Du, Jin Qiu, Fei Wang, Xue-peng Li · 2026 · Fish & Shellfish Immunology
  25. CRP (C-Reactive Protein) Revisited: An Old Yet New Biomarker of Acute and Chronic Inflammation
    Masayuki Nagasawa · 2026 · Cells
  26. Proteomic shifts post-plasma cell therapy in AL amyloid plaques and potential implications for light chain-directed anti-fibril monoclonal antibodies
    Matthew J. Rees, S. Dasari, Ellen D. McPhail, A. Dispenzieri, M. Charlesworth, Eli Muchtar, M. Gertz, Navin R. Gupta, Emilie I. Anderson, Samantha N Quang et al. · 2025 · Haematologica
  27. Osteoporosis-mediated exacerbation of the amyloid-β pathology: Involvement of serum calcium
    Zhe-Sheng Zhang, Rong-Rong Lin, Xu Liu, Min-Juan Li, Shuai Lu, Qing-Qing Tao · 2025 · Journal of Alzheimer's disease reports
  28. In-vitro Interaction of αB-Crystallin on Serum Amyloid A and Serum Amyloid A Fibrils with Hepta 1-6 Cells
    C. Asokan, I. Musthapha · 2015
  29. Understanding the dual nature of lysozyme: part villain – part hero : A Drosophila melanogaster model of lysozyme amyloidosis
    Linda Helmfors · 2014 · Linköping University Electronic Press eBooks
  30. Sopping up SAP
    T. Fulmer · 2010
  31. Serum amyloid P: A novel antifibrotic agent with therapeutic potential
    M. Lupher, W. Willett · 2010 · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research
  32. Pathogenese und Diagnostik von AA-Amyloidosen
    S. Elitok, R. Kettritz · 2008 · Der Nephrologe
  33. Amyloid diseases: A therapeutic knockout of SAP
    Adam Smith · 2002 · Nature reviews. Drug discovery
  34. Letters to the Editor
    D. Rudin, D. Gregory, S. Hyde, G. Herman · 2001 · Faculty Dental Journal
  35. Biomedical research—from numerators to denominators
    I. Perry · 1999 · Nature Medicine
  36. LETTERS TO THE EDITOR
    G. Bendersky, Stephen L. Sacks · 1997 · Source
  37. Amyloid-β and lysozyme proteotoxicity in Drosophila : Beneficial effects of lysozyme and serum amyloid P component in models of Alzheimer’s disease and lysozyme amyloidosis
    Liza Bergkvist · 2017 · Linköping studies in science and technology. Dissertations
  38. Protein Design
    Guerois Raphael, de la Paz Manuela López · 2006 · Methods in Molecular Biology
  39. Clinical features and management of amyloidosis
    P. Hawkins · 2003